Shorter DAPT Tested Following CABG
TOP-CABG compared 3 months vs 12 months of ticagrelor plus aspirin following bypass surgery.
By
Kathryn Wighton
June 8, 2026
Clinical Scorecard: Shorter DAPT Tested Following CABG
At a Glance
Category Detail
Condition Key Mechanisms Ticagrelor-based dual antiplatelet therapy (DAPT) for reducing SVG occlusion and bleeding risk. Target Population Care Setting
Key Highlights
Emphasize the clinical relevance of the noninferiority findings for SVG occlusion. Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Monitor for SVG occlusion and bleeding events within 1 year, including specific imaging techniques. Risks
Patient & Prescribing Data
Detail patient selection criteria for the 3-month DAPT strategy.
Clinical Best Practices
Include a note on excluding patients unable to tolerate early postoperative DAPT. Related Resources & Content
